This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n7http://localhost/temp/predkladatel/
n15http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n9http://linked.opendata.cz/ontology/domain/vavai/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n13http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11140%2F14%3A10227304%21RIV15-MSM-11140___/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n18http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11140%2F14%3A10227304%21RIV15-MSM-11140___
rdf:type
n9:Vysledek skos:Concept
rdfs:seeAlso
http://www.sciencedirect.com/science/article/pii/S0010865014000174
dcterms:description
This is the second iteration of the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) joining forces to write guidelines on the management of the combination of diabetes mellitus (DM), pre-diabetes, and cardiovascular disease (CVD), designed to assist clinicians and other healthcare workers to make evidence based management decisions. More than half the mortality and a vast amount of morbidity in people with DM are related to CVD, which caused physicians in the fields of DM and cardiovascular medicine to join forces to research and manage these conditions. Healthy eating, regular physical activity and cessation of smoking are first measures for the prevention and/or management of T2DM and other attending risk factors (hypertension, dyslipidemia, etc.) with targets of weight loss and reduction of CV risk. Patients with a short duration of T2DM and without a history of CVD, without trend to hypoglycaemia seemed to benefit from more-intensive glucose-lowering strategies (HbA1c 42-48 mmol/mol) for reducing long-term macrovascular complications. An HbA1c target of <53 mmol/mol to reduce microvascular disease is a generally accepted level. The choice of agent, the conditions of their use and the role of combination therapy have been extensively reviewed in the joint ADA/EASD guidelines. This is the second iteration of the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) joining forces to write guidelines on the management of the combination of diabetes mellitus (DM), pre-diabetes, and cardiovascular disease (CVD), designed to assist clinicians and other healthcare workers to make evidence based management decisions. More than half the mortality and a vast amount of morbidity in people with DM are related to CVD, which caused physicians in the fields of DM and cardiovascular medicine to join forces to research and manage these conditions. Healthy eating, regular physical activity and cessation of smoking are first measures for the prevention and/or management of T2DM and other attending risk factors (hypertension, dyslipidemia, etc.) with targets of weight loss and reduction of CV risk. Patients with a short duration of T2DM and without a history of CVD, without trend to hypoglycaemia seemed to benefit from more-intensive glucose-lowering strategies (HbA1c 42-48 mmol/mol) for reducing long-term macrovascular complications. An HbA1c target of <53 mmol/mol to reduce microvascular disease is a generally accepted level. The choice of agent, the conditions of their use and the role of combination therapy have been extensively reviewed in the joint ADA/EASD guidelines.
dcterms:title
ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with EASD: Summary of the document prepared by the Czech Society of Cardiology ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with EASD: Summary of the document prepared by the Czech Society of Cardiology
skos:prefLabel
ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with EASD: Summary of the document prepared by the Czech Society of Cardiology ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with EASD: Summary of the document prepared by the Czech Society of Cardiology
skos:notation
RIV/00216208:11140/14:10227304!RIV15-MSM-11140___
n3:aktivita
n8:I
n3:aktivity
I
n3:dodaniDat
n18:2015
n3:domaciTvurceVysledku
n15:5472539
n3:druhVysledku
n12:O
n3:duvernostUdaju
n16:S
n3:entitaPredkladatele
n6:predkladatel
n3:idSjednocenehoVysledku
14968
n3:idVysledku
RIV/00216208:11140/14:10227304
n3:jazykVysledku
n14:eng
n3:klicovaSlova
cardiovascular diseases; prediabetes; diabetes; ESC and EASD Guidelines
n3:klicoveSlovo
n4:cardiovascular%20diseases n4:diabetes n4:prediabetes n4:ESC%20and%20EASD%20Guidelines
n3:kontrolniKodProRIV
[A642618DC03C]
n3:obor
n17:FA
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
3
n3:rokUplatneniVysledku
n18:2014
n3:tvurceVysledku
Pelikánová, Terezie Moťovská, Zuzana Rosolová, Hana
n13:doi
10.10016/j.crva.2014.01.007
n7:organizacniJednotka
11140